Antagonism/Agonism Modulation to Build Novel Antihypertensives Selectively Triggering I1-Imidazoline Receptor Activation

被引:13
作者
Del Bello, Fabio [1 ]
Bargelli, Valentina [2 ]
Cifani, Carlo [3 ]
Gratteri, Paola [4 ,5 ,6 ]
Bazzicalupi, Carla [7 ]
Diamanti, Eleonora [1 ]
Giannella, Mario [1 ]
Mammoli, Valerio [1 ]
Matucci, Rosanna [2 ]
Di Bonaventura, Maria Vittoria Micioni [3 ]
Piergentili, Alessandro [1 ]
Quaglia, Wilma [1 ]
Pigini, Maria [1 ]
机构
[1] Univ Camerino, Med Chem Unit, Sch Pharm, I-62032 Camerino, Italy
[2] Univ Florence, Dept NEUROFARBA, Preclin & Clin Pharmacol, I-50139 Florence, Italy
[3] Univ Camerino, Sch Pharm, Pharmacol Unit, I-62032 Camerino, Italy
[4] Univ Florence, Dept NEUROFARBA, Pharmaceut & Nutraceut Sect, I-50019 Florence, Italy
[5] Univ Florence, Lab Mol Modeling Cheminformat, I-50019 Florence, Italy
[6] Univ Florence, QSAR, I-50019 Florence, Italy
[7] Univ Florence, Dept Chem Ugo Schiff, I-50019 Florence, Italy
关键词
imidazoline compounds; I-1-agonists; antihypertensive agents; bradicardic agents; stereoselectivity; carbomethyline; ALPHA(2)-ADRENORECEPTORS PROFILE MODULATION; IMIDAZOLINE BINDING-SITES; KEY ROLE; MOXONIDINE; ANALOGS;
D O I
10.1021/acsmedchemlett.5b00115
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pharmacological studies have suggested that I-1-imidazoline receptors are involved in the regulation of cardiovascular function and that selective I-1-agonists, devoid of the side effects associated with the common hypotensive alpha(2)-adrenoreceptor agonists, might be considered as a second generation of centrally acting antihypertensives. Therefore, in the present study, inspired by the antihypertensive behavior of our selective I-1-agonist 4, we designed, prepared, and studied the novel analogues 5-9. A selective I-1-profile, associated with significant hemodinamic effects, was displayed by 5, 8, and 9. Interestingly, the highest potency and longest lasting activity displayed by 8 (carbomethyline) suggested that van der Waals interactions, promoted by the ortho methyl decoration of its aromatic moiety, are particularly advantageous. In addition, in analogy to what was noted for (S)-(+)-4, the observation that only (S)-(+)-8 displayed significant hemodynamic effects unequivocally confirmed the stereospecific nature of the I-1 proteins.
引用
收藏
页码:496 / 501
页数:6
相关论文
共 28 条
[1]  
BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232
[2]   Might Adrenergic α2C-Agonists/α2A-Antagonists Become Novel Therapeutic Tools for Pain Treatment with Morphine? [J].
Cardinaletti, Claudia ;
Mattioli, Laura ;
Ghelfi, Francesca ;
Del Bello, Fabio ;
Giannella, Mario ;
Bruzzone, Ariana ;
Paris, Herve ;
Perfumi, Marina ;
Piergentili, Alessandro ;
Quaglia, Wilma ;
Pigini, Maria .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (22) :7319-7322
[3]   Imidazoline binding sites and their ligands: An overview of the different chemical structures [J].
Dardonville, C ;
Rozas, I .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (05) :639-661
[4]   Exploring Multitarget Interactions to Reduce Opiate Withdrawal Syndrome and Psychiatric Comorbidity [J].
Del Bello, Fabio ;
Diamanti, Eleonora ;
Giannella, Mario ;
Mammoli, Valerio ;
Mattioli, Laura ;
Titomanlio, Federica ;
Piergentili, Alessandro ;
Quaglia, Wilma ;
Lanza, Marco ;
Sabatini, Chiara ;
Caselli, Gianfranco ;
Poggesi, Elena ;
Pigini, Maria .
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (09) :875-879
[5]   Might the observed α2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? [J].
Diamanti, Eleonora ;
Del Bello, Fabio ;
Carbonara, Giuseppe ;
Carrieri, Antonio ;
Fracchiolla, Giuseppe ;
Giannella, Mario ;
Mammoli, Valerio ;
Piergentili, Alessandro ;
Pohjanoksa, Katariina ;
Quaglia, Wilma ;
Scheinin, Mika ;
Pigini, Maria .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (06) :2082-2090
[6]  
Emsberg P., 1990, J PHARMACOL EXP THER, V253, P408
[7]   Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis [J].
Fairbanks, Carolyn A. ;
Stone, Laura S. ;
Wilcox, George L. .
PHARMACOLOGY & THERAPEUTICS, 2009, 123 (02) :224-238
[8]   A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats [J].
Fellmann, Lyne ;
Regnault, Veronique ;
Greney, Hugues ;
Gasparik, Vincent ;
Muscat, Adeline ;
Max, Jean-Pierre ;
Gigou, Luc ;
Orea, Valerie ;
Chetrite, Gerard ;
Pizard, Anne ;
Niederhoffer, Nathalie ;
Julien, Claude ;
Lacolley, Patrick ;
Feve, Bruno ;
Bousquet, Pascal .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 346 (03) :370-380
[9]   α2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole [J].
Gentili, F ;
Bousquet, P ;
Brasili, L ;
Caretto, M ;
Carrieri, A ;
Dontenwill, M ;
Giannella, M ;
Marucci, G ;
Perfumi, M ;
Piergentili, A ;
Quaglia, W ;
Rascente, C ;
Pigini, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (01) :32-40
[10]   α2-adrenoreceptors profile modulation.: 2.: Biphenyline analogues as tools for selective activation of the α2C-subtype [J].
Gentili, F ;
Ghelfi, F ;
Giannella, M ;
Piergentili, A ;
Pigini, M ;
Quaglia, W ;
Vesprini, C ;
Crassous, PA ;
Paris, H ;
Carrieri, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6160-6173